Literature DB >> 23395552

Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse.

Yugo Ando1, Guo-Xiang Yang, Thomas P Kenny, Kazuhito Kawata, Weici Zhang, Wenting Huang, Patrick S C Leung, Zhe-Xiong Lian, Kazuichi Okazaki, Aftab A Ansari, Xiao-Song He, Pietro Invernizzi, William M Ridgway, Qianjin Lu, M Eric Gershwin.   

Abstract

Dominant-negative TGF-β receptor II (dnTGF-βRII) mice spontaneously develop an autoimmune cholangitis resembling human primary biliary cirrhosis (PBC). Interestingly, the dominant-negative TGF-β receptor is expressed by both CD4(+) and CD8(+) T cells and leads to greatly reduced (but not absent) TGF-β signaling resulting in T cell intrinsic cell mediated autoimmunity. However, the mechanisms of the T cell dysregulation remain unclear. Recently it has been shown that TGF-β signaling is intimately involved with miRNA biogenesis and control. Herein we show that lack of T cell TGF-β signaling leads to down regulation of T cell miRNAs but up-regulation of the key inflammatory miRNA 21. Furthermore, the expression of miR-21 from hepatic effector CD8(+) T cells is significantly higher than in the same subsets isolated from spleen and mesenteric lymph nodes of the dnTGF-βRII mice. Previous studies indicate that miR-21 increases the synthesis of IFN-γ and IL-17A by T cells and suppresses apoptosis via programmed cell death protein 4 (PDCD4). Data presented herein demonstrate that transfecting w.t. B6 T cell subsets with miR-21 resulted in up-regulation of the inflammatory cytokines TNF-α and IFN-γ, thus partly replicating the dnTGF-βRII T cell phenotype. In conclusion, these data suggest miR-21 plays a critical role in the production of pro-inflammatory cytokines in dnTGF-βRII mice, which could be a contributing factor for the development of the organ-specific autoimmune cholangitis and colitis in this murine model of human PBC.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23395552      PMCID: PMC3622842          DOI: 10.1016/j.jaut.2012.12.013

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  48 in total

Review 1.  The microRNA world: small is mighty.

Authors:  Peter Nelson; Marianthi Kiriakidou; Anup Sharma; Elsa Maniataki; Zissimos Mourelatos
Journal:  Trends Biochem Sci       Date:  2003-10       Impact factor: 13.807

2.  The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice.

Authors:  Yugo Ando; Guo-Xiang Yang; Masanobu Tsuda; Kazuhito Kawata; Weici Zhang; Takahiko Nakajima; Koichi Tsuneyama; Patrick Leung; Zhe-Xiong Lian; Kazuichi Okazaki; William M Ridgway; Gary L Norman; Aftab A Ansari; Xiao-Song He; Ross L Coppel; M Eric Gershwin
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

Review 3.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

Review 4.  The NF-kappa B and I kappa B proteins: new discoveries and insights.

Authors:  A S Baldwin
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

5.  Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation.

Authors:  Dirk Haller; Lisa Holt; Sandra C Kim; Robert F Schwabe; R Balfour Sartor; Christian Jobin
Journal:  J Biol Chem       Date:  2003-04-02       Impact factor: 5.157

Review 6.  Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis.

Authors:  T S Finco; A S Baldwin
Journal:  Immunity       Date:  1995-09       Impact factor: 31.745

7.  Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease.

Authors:  L Gorelik; R A Flavell
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

8.  DNA damage induces NF-κB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion.

Authors:  Jixiao Niu; Yuling Shi; Guangyun Tan; Chuan He Yang; Meiyun Fan; Lawrence M Pfeffer; Zhao-Hui Wu
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

9.  Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations.

Authors:  Zhe-Xiong Lian; Tomoyuki Okada; Xiao-Song He; Hiroto Kita; Yong-Jun Liu; Aftab A Ansari; Kentaro Kikuchi; Susumu Ikehara; M Eric Gershwin
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

10.  Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease.

Authors:  Timothy S Olson; Giorgos Bamias; Makoto Naganuma; Jesús Rivera-Nieves; Tracy L Burcin; William Ross; Margaret A Morris; Theresa T Pizarro; Peter B Ernst; Fabio Cominelli; Klaus Ley
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

View more
  46 in total

1.  The challenge of treating orphan disease.

Authors:  Carlos Dias; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

2.  Spaceflight alters expression of microRNA during T-cell activation.

Authors:  Millie Hughes-Fulford; Tammy T Chang; Emily M Martinez; Chai-Fei Li
Journal:  FASEB J       Date:  2015-08-14       Impact factor: 5.191

Review 3.  microRNAs function in CD8+T cell biology.

Authors:  Yan Liang; Hai-Feng Pan; Dong-Qing Ye
Journal:  J Leukoc Biol       Date:  2015-01-05       Impact factor: 4.962

Review 4.  IL-35 and Autoimmunity: a Comprehensive Perspective.

Authors:  Jinjung Choi; Patrick S C Leung; Christopher Bowlus; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

5.  Unmet challenges in immune-mediated hepatobiliary diseases.

Authors:  Ulrich Beuers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

6.  Immunological potential of cytotoxic T lymphocyte antigen 4 immunoglobulin in murine autoimmune cholangitis.

Authors:  H Tanaka; G-X Yang; T Tomiyama; K Tsuneyama; W Zhang; P S C Leung; R L Coppel; T Joh; S G Nadler; A A Ansari; C Bowlus; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2015-06       Impact factor: 4.330

Review 7.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 8.  Extrahepatic autoimmune conditions associated with primary biliary cirrhosis.

Authors:  Annarosa Floreani; Irene Franceschet; Nora Cazzagon; Alice Spinazzè; Alessandra Buja; Patrizia Furlan; Vincenzo Baldo; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

9.  Innate immunity drives xenobiotic-induced murine autoimmune cholangitis.

Authors:  C-H Chang; Y-C Chen; Y-H Yu; M-H Tao; P S C Leung; A A Ansari; M E Gershwin; Y-H Chuang
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

10.  Unique topics and issues in rheumatology and clinical immunology.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.